Discover Baxter International's Q4 2024 earnings insights, including recovery milestones, Novum IQ pump success, and a promising 2025 growth outlook.

Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. On its fourth attempt to pass muster with the FDA, the company’s SPN-830 ...

Deerfield-based Baxter International announced Monday that its CEO and board Chair José Almeida is retiring, effective immediately — an announcement that came just days after the company sold ...

He will serve in an advisory capacity through Oct. 31, 2025. The Baxter Board of Directors has appointed lead independent director Brent Shafer as chair and interim CEO and has initiated a search ...

Baxter President and CEO José Almeida has announced his retirement, effective immediately, after nearly a decade of leading the medtech company. The news comes just days after Baxter completed ...

DEERFIELD, Ill., February 03, 2025--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that José (Joe) E. Almeida, chair, president and chief ...

Feb. 03, 2025 (GLOBE NEWSWIRE) -- Vantive, formerly the Baxter Kidney Care segment, today launched as a new standalone vital organ therapy company following the completion of its acquisition by ...

Feb 3 (Reuters) - Medical products maker Baxter International (BAX.N), opens new tab said on Monday its CEO José Almeida will retire effective immediately, after nearly a decade as the company's ...

Baxter International BAX announced longtime CEO Joe Almeida would be retiring immediately, without a successor in place, while suggesting that the firm’s 2025 guidance would likely decline due ...

The FDA (7) classifies adverse events related to infusion pumps according to their cause: software problems, alarm errors, inadequate user interface design (“human factors” problems), broken ...

Fraser Elliott Building, 190 Elizabeth Street, Toronto, ON, Canada M5G 2C4; patricia.trbovich{at}uhn.on.ca Objective Assess the impact of infusion pump technologies (traditional pump vs smart pump vs ...

Baxter International seems pretty uncompelling as an investment opportunity, and investors should look elsewhere. Even so, within each business segment, we see there are different important ...